Companies: 10,795·Total market cap: $144.5T
Kura Oncology, Inc.

Kura Oncology, Inc.

KURANASDAQHealthcare● Active
$8.58
$-0.16(-1.84%)
Market Cap$761577522
P/E Ratio
52W High$12.49
52W Low$5.45

Kura Oncology, Inc. (KURA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KURA · as of Mar 5, 2026

Latest filing snapshot

260
+68+35.42%vs prior year

Kura Oncology, Inc. (KURA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
260
Change (1Y)
+68
Growth % (1Y)
+35.42%
Revenue / Employee
$259.5K
Net Income / Employee
$-1.07M
Market Cap
$752M

KURA Employee Count

2008 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-05260+68+35.42%
2025-02-28192+50+35.21%
2024-02-27142+9+6.77%
2023-02-23133+12+9.92%
2022-02-24121+32+35.96%
2021-02-2489+29+48.33%
2020-02-2560+17+39.53%
2019-03-0543+12+38.71%
2018-03-1231+9+40.91%
2017-03-1422+1+4.76%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Maravai LifeSciences Holdings, Inc.
MRVI
Maravai LifeSciences Holdings, Inc.
570
#2
Replimune Group, Inc.
REPL
Replimune Group, Inc.
479
#3
Kura Oncology, Inc.
KURA
Kura Oncology, Inc.YOU
260
#4
Prime Medicine, Inc.
PRME
Prime Medicine, Inc.
214
#5
ProKidney Corp.
PROK
ProKidney Corp.
204
#6
EyePoint Pharmaceuticals, Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
165
#7
Bicara Therapeutics Inc. Common Stock
BCAX
Bicara Therapeutics Inc. Common Stock
55
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KURA peer comparison

About KURA employees

KURA Employees · Headcount

Kura Oncology, Inc. (KURA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Kura Oncology, Inc. had 260 full-time employees globally. Full-time employees only. Global consolidated headcount.

Kura Oncology, Inc. employs 260 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $259,546, reflecting the company's operational efficiency.

Kura Oncology, Inc.'s workforce increased by 68 (35.42%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Kura Oncology, Inc.'s revenue per employee of $259,546 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

KURA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Kura Oncology, Inc. had 260 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Kura Oncology, Inc. employee counthow many employees does Kura Oncology, Inc. haveKURA total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-05